NAMS Menopause Certification Exam
Questions and Answers (Graded A+) | 2026/2027
100 Questions | NCMP Exam Blueprint Aligned | Evidence-Based Rationales
Section 1: Menopause Physiology and STRAW+10 Staging
Reproductive Aging, Hormonal Changes, and Ovarian Function (Q1-Q20)
Q1: A 49-year-old woman reports that her menstrual cycles have become irregular over the past 6 months. She notes
that her last two cycles differed in length by 10 days. According to the STRAW+10 staging system, which
reproductive stage best describes this patient?
A. Stage -2 (Early Menopause Transition) [CORRECT]
B. Stage -1 (Late Menopause Transition)
C. Stage +1a (Early Postmenopause)
D. Stage -3 (Late Reproductive Stage)
Correct Answer: A
Rationale: STRAW+10 Stage -2 (Early Menopause Transition) is defined by a persistent difference of 7 or more days in the length of
consecutive cycles. This patient's 10-day difference meets this criterion. Stage -1 (Late Transition) requires 60 or more consecutive days of
amenorrhea, which this patient has not experienced. Stage +1a is the first year after the final menstrual period, and Stage -3 is the late
reproductive stage with regular cycles and no cycle length variability.
Q2: A 52-year-old woman presents reporting that she has not had a menstrual period for 14 months. Her FSH level is
78 IU/L. Which STRAW+10 stage is she most likely in?
A. Stage -1 (Late Menopause Transition)
B. Stage 0 (Final Menstrual Period) [CORRECT]
C. Stage +1a (Early Postmenopause)
D. Stage +2 (Late Postmenopause)
Correct Answer: B
Rationale: Stage 0 represents the Final Menstrual Period (FMP), which is identified retrospectively after 12 consecutive months of
amenorrhea. This patient has had 14 months without a period, so her FMP occurred 14 months ago. However, the FMP itself is classified as
Stage 0, and the early postmenopausal stages (+1a through +1c) follow. Since the question asks which stage she is currently in and 14
months of amenorrhea places her in early postmenopause, the FMP itself is identified as Stage 0. The elevated FSH is consistent with the
postmenopausal state.
Q3: A 47-year-old woman reports amenorrhea for the past 3 months. Prior to this, her cycles had been regular. She is
not on any hormonal therapy. According to STRAW+10, what is the minimum period of amenorrhea required to
classify her as being in the Late Menopause Transition (Stage -1)?
A. 30 consecutive days
B. 45 consecutive days
C. 60 consecutive days [CORRECT]
D. 90 consecutive days
Correct Answer: C
, NAMS Menopause Certification Exam 2026/2027 | 100 Questions & Verified Answers (Graded A+)
Rationale: According to the STRAW+10 staging system, Stage -1 (Late Menopause Transition) is characterized by 60 or more consecutive
days of amenorrhea. This patient meets the criterion with 90 days (approximately 3 months) of amenorrhea. The 30-day and 45-day
thresholds are not part of the STRAW+10 classification. The 90-day criterion is sometimes used clinically but the formal STRAW+10
threshold for late transition is 60 days.
Q4: A clinician is evaluating a 42-year-old woman with oligomenorrhea and elevated FSH. Which biomarker is most
useful for predicting the timing of the final menstrual period in perimenopausal women?
A. Inhibin B
B. Follicle-stimulating hormone (FSH)
C. Estradiol
D. Anti-Mullerian Hormone (AMH) [CORRECT]
Correct Answer: D
Rationale: AMH is the most useful biomarker for predicting the timing of the final menstrual period in perimenopausal women because it
reflects the remaining ovarian follicle pool and declines progressively as menopause approaches. Inhibin B also decreases but is less
predictive. FSH and estradiol fluctuate substantially during the menopause transition and are not reliable predictors of the FMP. AMH is
also particularly useful in the diagnosis of Primary Ovarian Insufficiency (POI), where levels are very low or undetectable.
Q5: What is the average age of natural menopause in the general population?
A. 45 years
B. 48 years
C. 51 years [CORRECT]
D. 55 years
Correct Answer: C
Rationale: The average age of natural menopause in the general population is approximately 51 years. Early menopause is defined as
occurring between ages 40 and 45, while premature menopause (also called Primary Ovarian Insufficiency) occurs before age 40. The
average age can vary by ethnicity and geographic region, but 51 is the widely accepted average cited in NAMS guidelines and
epidemiological studies.
Q6: A 38-year-old woman presents with amenorrhea for 4 months, hot flashes, and night sweats. Her FSH on two
occasions, 4 weeks apart, is 42 IU/L and 48 IU/L. Which of the following is the most likely diagnosis?
A. Natural menopause
B. Early menopause
C. Primary Ovarian Insufficiency (POI) [CORRECT]
D. Hypothalamic amenorrhea
Correct Answer: C
Rationale: Primary Ovarian Insufficiency (POI) is diagnosed in women under age 40 with amenorrhea of 3 to 4 months or more and
elevated FSH (25 IU/L or greater) on two checks performed 4 to 6 weeks apart. This patient meets all three criteria: age under 40,
amenorrhea for 4 months, and FSH consistently above 25 IU/L. Natural menopause occurs at the average age of 51. Early menopause is
defined as occurring between ages 40 and 45. Hypothalamic amenorrhea typically presents with low or normal FSH, not elevated FSH.
Q7: A perimenopausal woman undergoing evaluation for irregular bleeding has a transiently elevated estradiol level
that is not consistent with her expected follicular phase. The clinician suspects a Luteal Out-of-Phase (LOOP) event.
What is the mechanism of a LOOP event?
A. Decreased inhibin B causes an exaggerated FSH surge leading to multiple follicle recruitment
B. Elevated FSH recruits a second follicle, causing transient estradiol elevation [CORRECT]
C. The corpus luteum fails to regress, producing excess progesterone
D. Increased androgen production from stromal cells stimulates estradiol synthesis
, NAMS Menopause Certification Exam 2026/2027 | 100 Questions & Verified Answers (Graded A+)
Correct Answer: B
Rationale: A Luteal Out-of-Phase (LOOP) event occurs when elevated FSH recruits a second follicle during the luteal phase or in the early
follicular phase of the next cycle, causing a transient estradiol elevation. This phenomenon is characteristic of the menopause transition
when FSH levels are rising and fluctuating. It is not caused by decreased inhibin B, corpus luteum failure, or stromal androgen production.
Q8: Which of the following statements regarding inhibin B and AMH during the menopause transition is correct
according to NAMS guidelines?
A. Inhibin B increases as the follicle pool diminishes
B. AMH is the first hormone to decline, even before FSH rises [CORRECT]
C. Both inhibin B and AMH increase during the late menopause transition
D. AMH is primarily produced by the corpus luteum
Correct Answer: B
Rationale: AMH is produced by granulosa cells of small antral follicles and is the first hormone to decline during reproductive aging, even
before FSH begins to rise. This makes AMH a sensitive early marker of diminished ovarian reserve. Inhibin B also decreases, allowing
growth of the remaining follicle pool, but AMH declines earlier and more consistently. Both hormones decrease, not increase, during the
transition. AMH is produced by ovarian follicles, not the corpus luteum.
Q9: A 53-year-old woman asks whether laboratory testing is necessary to confirm that she has reached menopause.
According to NAMS guidelines, which of the following is true regarding FSH and estradiol testing in women over age
45?
A. FSH and estradiol are required for diagnosis in all women over 45
B. FSH and estradiol are not required for diagnosis in women over 45 with typical symptoms [CORRECT]
C. FSH must be drawn on day 3 of the menstrual cycle for accuracy
D. Estradiol is the most reliable laboratory marker for diagnosing menopause
Correct Answer: B
Rationale: NAMS guidelines state that FSH and estradiol are not required for the diagnosis of menopause in women over age 45 who
present with typical vasomotor symptoms and menstrual pattern changes. The diagnosis can be made clinically based on 12 months of
amenorrhea. FSH and estradiol fluctuate substantially during the menopause transition and are not reliable for diagnosis in this age group.
Laboratory testing may be helpful in younger women, those with atypical presentations, or when evaluating for POI.
Q10: A woman in Stage +1c of the STRAW+10 system asks her clinician what to expect. How many years after the
FMP does Stage +1c represent?
A. First year after the FMP
B. Second year after the FMP
C. Third year after the FMP [CORRECT]
D. Fourth year after the FMP
Correct Answer: C
Rationale: In the STRAW+10 staging system, Stage +1c represents the third year after the Final Menstrual Period (FMP). The early
postmenopausal period is divided into three substages: +1a (first year), +1b (second year), and +1c (third year). Stage +2 (Late
Postmenopause) begins approximately 5 to 8 years after the FMP, during which somatic aging predominates and genitourinary symptoms of
menopause increase.
Q11: A 44-year-old woman presents with irregular menses and an FSH of 18 IU/L. She asks about the difference
between early menopause and premature menopause. Which of the following correctly distinguishes these
categories?
A. Early menopause occurs at age 35-40; premature menopause occurs at age less than 35
B. Early menopause occurs at age 40-45; premature menopause occurs at age less than 40 [CORRECT]